JP2009509979A5 - - Google Patents

Download PDF

Info

Publication number
JP2009509979A5
JP2009509979A5 JP2008532546A JP2008532546A JP2009509979A5 JP 2009509979 A5 JP2009509979 A5 JP 2009509979A5 JP 2008532546 A JP2008532546 A JP 2008532546A JP 2008532546 A JP2008532546 A JP 2008532546A JP 2009509979 A5 JP2009509979 A5 JP 2009509979A5
Authority
JP
Japan
Prior art keywords
serpin
granzyme
cell
composition
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008532546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009509979A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2006/001582 external-priority patent/WO2007036028A1/en
Publication of JP2009509979A publication Critical patent/JP2009509979A/ja
Publication of JP2009509979A5 publication Critical patent/JP2009509979A5/ja
Pending legal-status Critical Current

Links

JP2008532546A 2005-09-29 2006-09-26 グランザイムb阻害のための組成物および方法 Pending JP2009509979A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72179905P 2005-09-29 2005-09-29
PCT/CA2006/001582 WO2007036028A1 (en) 2005-09-29 2006-09-26 Compositions for and methods of granzyme b inhibition

Publications (2)

Publication Number Publication Date
JP2009509979A JP2009509979A (ja) 2009-03-12
JP2009509979A5 true JP2009509979A5 (enExample) 2010-11-18

Family

ID=37899312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532546A Pending JP2009509979A (ja) 2005-09-29 2006-09-26 グランザイムb阻害のための組成物および方法

Country Status (6)

Country Link
US (2) US20070104699A1 (enExample)
EP (1) EP1940458A4 (enExample)
JP (1) JP2009509979A (enExample)
AU (1) AU2006297036A1 (enExample)
CA (1) CA2623957A1 (enExample)
WO (1) WO2007036028A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951776B2 (en) * 2006-09-01 2011-05-31 American Type Culture Collection Methods for treatment of type 1 diabetes
CA2739512A1 (en) 2007-10-01 2009-04-09 The University Of British Columbia Granzyme a and granzyme b diagnostics
JP5959800B2 (ja) * 2007-10-01 2016-08-02 ザ ユニバーシティ オブ ブリティッシュ コロンビア グランザイムbインヒビターを用いる解離,動脈瘤,およびアテローム性動脈硬化症の治療
CA2819810A1 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
US11559590B2 (en) 2016-07-01 2023-01-24 The General Hospital Corporation Granzyme B directed imaging and therapy
CN119345374A (zh) * 2024-10-31 2025-01-24 南通大学 靶向颗粒酶b在帕金森病神经元退变免疫治疗药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266465A (en) * 1989-06-23 1993-11-30 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5612194A (en) * 1989-06-23 1997-03-18 Trustees Of The University Of Pennsylvania Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
US5674708A (en) * 1989-06-23 1997-10-07 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having elastase inhibitory activity
DE10121255A1 (de) * 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
EP1474093A4 (en) * 2002-02-04 2005-02-16 Merck & Co Inc Granzyme B INHIBITORS
US7074911B2 (en) * 2002-09-25 2006-07-11 Board Of Regents, The University Of Texas System Endogenous granzyme B in non-immune cells
JP2005120070A (ja) * 2003-03-10 2005-05-12 Taisho Pharmaceut Co Ltd エラスターゼ遊離抑制剤及び脳梗塞治療薬
WO2004113523A1 (ja) * 2003-06-18 2004-12-29 Celestar Lexico-Sciences, Inc. Granzyme BとGolgin-160との相互作用阻害剤
JP2005060379A (ja) * 2003-07-31 2005-03-10 Dainippon Pharmaceut Co Ltd 複素環式化合物からなる医薬
SE0302487D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
EP1879448A2 (en) * 2005-02-25 2008-01-23 University of Chicago Compositions and methods related to serpin spi6

Similar Documents

Publication Publication Date Title
Resch et al. Transplanting marginal organs in the era of modern machine perfusion and advanced organ monitoring
Stockmann et al. Extracorporeal perfusion for the treatment of acute liver failure
Nagamoto et al. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure
Kim et al. Up to 9‐day survival and control of thrombocytopenia following alpha1, 3‐galactosyl transferase knockout swine liver xenotransplantation in baboons
Starzl History of liver and other splanchnic organ transplantation
BRPI0519783A2 (pt) composições imunogênicas de pvc2 e métodos de produzir tais composições
WO2005121369A3 (en) Rna-containing microvesicles and methods therefor
Watanabe et al. GalT‐KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD 47 on porcine blood vessels
Zhang et al. Artificial matrix helps neonatal cardiomyocytes restore injured myocardium in rats
JP2005534430A5 (enExample)
JP2009509979A5 (enExample)
Tatsumi et al. Therapeutic effects of hepatocyte transplantation on hemophilia B
Wu et al. Multiple gene modifications of pigs for overcoming obstacles of xenotransplantation
JP2005528124A5 (enExample)
JP2008526318A5 (enExample)
Cypel et al. Extracorporeal lung perfusion
Rosenthal et al. Techniques for intrasplenic hepatocyte transplantation in the large animal model
Meyburg et al. Liver cell transplantation in children
EP1906729A4 (en) Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use
CN102985532B (zh) 胰岛的分离方法及用于保护胰岛组织的保护液
Duncan Mechanical support for cardiac and respiratory failure in pediatric patients
Blankensteijn et al. New aspects of heterotopic liver transplantation
Suzuki et al. Selective cell dissemination into the heart by retrograde intracoronary infusion in the rat1
CN116286992A (zh) 一种基于kferq序列的药物控制系统及其构建方法和应用
Li et al. Transplantation of neonatal cardiomyocytes plus fibrin sealant restores myocardial function in a rat model of myocardial infarction